Table 5.
Comparison of the studied groups in pancreatic GPX, CAT, MDA, and SOD levels.
| Groups | GPX (U/g) |
CAT (U/g) |
MDA (U/g) |
SOD (U/g) |
|---|---|---|---|---|
| Group 1 (Control) |
34.1 ± 3.0 | 1.7 ± 0.2 | 3.1 ± 0.2 | 21.5 ± 1.2 |
| Group 2 (STZ) |
7.4 ± 0.2 * | 0.24 ± 0.05 * | 80.3 ± 1.2 * | 5.4 ± 0.3 * |
| Group 3 (STZ and STG) |
20.9 ± 1.5 *# | 1.0 ± 0.2 *# | 20.0 ± 0.8 *# | 14.0 ± 0.8 *# |
| Group 4 (STZ and STG/Cu) |
22.06 ± 0.68 *# | 1.03 ± 0.01 *# | 17.68 ± 0.85 *# | 17.29 ± 1.25 # |
| Group 5 (STZ and STG/Mg) |
24.88 ± 0.45 # | 1.45 ± 0.1 # | 10.02 ± 1.36 # | 18.05 ± 1.59 # |
| Group 6 (STZ and STG/Zn) |
31.0 ± 1.6 # | 1.60 ± 0.3 # | 7.9 ± 0.7 # | 19.9 ± 1.3 # |
| Group 7 (STZ and STG/Ca) |
29.58 ± 1.78 # | 1.54 ± 0.02 # | 8.05 ± 1.58 # | 19.05 ± 1.36 # |
| Group 8 (STZ and STG/Cr) |
32.17 ± 2.36 # | 1.68 ± 0.05 # | 4.98 ± 1.02 # | 20.54 ± 1.98 # |
| Group 9 (STZ and STG/Se) |
30.25 ± 2.58 # | 1.34 ± 0.04 # | 5.25 ± 1.32 # | 19.85 ± 2.05 # |
| p-value | <0.001 (HS) | <0.001 (HS) | <0.001 (HS) | <0.001 (HS) |
Data are presented as mean ± SD. * Significant difference compared to the control group; # Significant difference compared to the STZ group. HS: highly significant.